Lisa Rosenbaum.

I cannot actually picture their faces. The blanks on our screens can be filled with terms, but the procedure of understanding can’t be auto-populated. Life without the EHR will soon be unimaginable Perhaps. But the technology shall support and improve health care only when it evolves with techniques that help, rather than hinder, us in synthesizing, analyzing, thinking critically, and informing the complete stories of our sufferers. Sam Gandy, M.D., Ph.D. Of Mount Sinai Alzheimer’s Disease Research Middle, New York, will address New Treatment Developments in Alzheimer’s, including treatments which have the greatest potential for entering clinical practice within the next few years – bapineuzumab, latrepirdine, and gamma secretase inhibitors. He also will contact on intriguing science that may describe the hyperlink between Alzheimer’s and diabetes.Experts say the results demonstrate the need for better collaboration between doctors and health authorities on a global scale, to ensure patients get access to the very best treatments. Coordinated actions is needed at a global level to make sure new cancer-fighting medications are approved regularly, oncologists stated at the Congress. Their call came after a study revealed that patients in some regions occasionally wait years much longer than their counterparts somewhere else for new medications to be approved. The drug approval process is important to ensure that safe and effective therapies are made designed for patients, explains study senior author Dr Sunil Verma from Sunnybrook Odette Cancer tumor Middle, Toronto, Canada.